{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:46:25Z","timestamp":1768891585120,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Time to peak creatine phosphokinase (CPK) has historically been used as a surrogate marker of reperfusion in ST-elevation myocardial infarction (STEMI), but its significance in the contemporary primary percutaneous coronary intervention (PCI) era remains uncertain. We retrospectively analyzed 239 consecutive STEMI patients who underwent primary PCI at Tsukazaki Hospital between January 2021 and December 2024. Patients were categorized according to final post-PCI TIMI flow: TIMI 3 (Group A, n=194) and non-TIMI 3 (Group B, n=45). The median time to peak CPK was significantly shorter in Group A compared with Group B (365.0 vs. 684.0 minutes, p&lt;0.001), whereas peak CPK levels did not differ significantly between the groups. At 30 days, the incidence of major adverse cardiovascular events plus congestive heart failure was significantly lower in Group A than in Group B (4.1% vs. 13.3%, log-rank p=0.01). These findings suggest that optimal post-PCI TIMI 3 flow is associated with faster enzymatic washout and better short-term outcomes, and that time to peak CPK may provide complementary information regarding reperfusion quality in STEMI patients.<\/jats:p>","DOI":"10.1186\/s12872-025-05416-x","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T09:05:37Z","timestamp":1765530337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delayed CPK peak after primary PCI in STEMI: marker of reperfusion quality and short-term outcomes"],"prefix":"10.1186","volume":"26","author":[{"given":"Eitaro","family":"Umehara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunpei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arata","family":"Hagikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kusuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"4","key":"5416_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/FJC.0000000000000980","volume":"77","author":"H Kakavand","year":"2021","unstructured":"Kakavand H, Aghakouchakzadeh M, Coons JC, Talasaz AH. Pharmacologic prevention of myocardial ischemia\u2013reperfusion injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention. J Cardiovasc Pharmacol. 2021;77(4):430\u201349.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"15","key":"5416_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/0002-9149(87)90896-4","volume":"59","author":"JM Gore","year":"1987","unstructured":"Gore JM, Roberts R, Ball SP, Montero A, Goldberg RJ, Dalen JE. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction. Am J Cardiol. 1987;59(15):1234\u20138.","journal-title":"Am J Cardiol"},{"issue":"5","key":"5416_CR3","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/01.CIR.87.5.1542","volume":"87","author":"M Zabel","year":"1993","unstructured":"Zabel M, Hohnloser SH, K\u00f6ster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation. 1993;87(5):1542\u201350.","journal-title":"Circulation"},{"issue":"4","key":"5416_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2217\/fca.09.25","volume":"5","author":"J De Haeck","year":"2009","unstructured":"De Haeck J, Verouden NJW, Henriques JPS, Koch KT. Current status of distal embolization in percutaneous coronary intervention: mechanical and pharmacological strategies. Future Cardiol. 2009;5(4):385\u2013402.","journal-title":"Future Cardiol"},{"issue":"12","key":"5416_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.amjmed.2006.08.019","volume":"119","author":"AJ Kirtane","year":"2006","unstructured":"Kirtane AJ, Gibson CM. Distal embolization of thrombus in acute myocardial infarction. Am J Med. 2006;119(12):e1\u20132.","journal-title":"Am J Med"},{"issue":"5","key":"5416_CR6","first-page":"1142","volume":"105","author":"D Strepkos","year":"2025","unstructured":"Strepkos D, Alexandrou M, Mutlu D, Carvalho PEP, Ser OS, Jalli S. Impact of side branch occlusion on patient outcomes after bifurcation percutaneous coronary intervention. Catheter Cardiovasc Interv. 2025;105(5):1142\u20138.","journal-title":"Catheter Cardiovasc Interv"},{"key":"5416_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJM198504043121437","volume":"312","author":"TIMI Study Group","year":"1985","unstructured":"TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:932\u20136.","journal-title":"N Engl J Med"},{"issue":"12","key":"5416_CR8","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1253\/circj.CJ-22-0032","volume":"86","author":"S Satomi Ishihara","year":"2022","unstructured":"Satomi Ishihara S, Hiramitsu K, Kanaoka M, Taki H, Nakagawa T, Ueda, et al. New conversion formula between B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide: analysis from a multicenter study. Circ J. 2022;86(12):2010\u20138.","journal-title":"Circ J"},{"issue":"2","key":"5416_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4244\/EIJV9I2A37","volume":"9","author":"A Caixeta","year":"2013","unstructured":"Caixeta A, Lansky AJ, Mehran R, Stone GW, Witzenbichler B, Parise H, et al. Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. EuroIntervention. 2013;9(2):220\u20137.","journal-title":"EuroIntervention"},{"issue":"1","key":"5416_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jcin.2008.10.006","volume":"2","author":"RH Mehta","year":"2009","unstructured":"Mehta RH, Ou FS, Peterson ED, Shaw RE, Hillegass WB, Rumsfeld JS, et al. Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2009;2(1):56\u201364.","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"5416_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jacc.2008.05.009","volume":"52","author":"G Ndrepepa","year":"2008","unstructured":"Ndrepepa G, Mehilli J, Schulz S, Iijima R, Keta D, Byrne RA, et al. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes. J Am Coll Cardiol. 2008;52(7):512\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5416_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","volume":"54","author":"G Niccoli","year":"2009","unstructured":"Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54(4):281\u201392.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5416_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jacasi.2024.12.013","volume":"5","author":"E Shibahashi","year":"2025","unstructured":"Shibahashi E, Kawakami R, Fukushima N, Yamashita T, Hasegawa Y, Suzuki M, et al. Prognostic significance of time between balloon and peak CK-MB in AMI patients undergoing primary PCI. JACC Asia. 2025;5(5):650\u20139.","journal-title":"JACC Asia"},{"issue":"5","key":"5416_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1536\/ihj.46.771","volume":"46","author":"T Katayama","year":"2005","unstructured":"Katayama T, Nakashima H, Takagi C, Yamamoto T, Kobayashi Y, Tanaka S, et al. Prognostic significance of time-delay to peak creatine kinase after direct percutaneous coronary intervention in acute myocardial infarction patients. Int Heart J. 2005;46(5):771\u201381.","journal-title":"Int Heart J"},{"issue":"1","key":"5416_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12872-020-01673-0","volume":"20","author":"K Elakabawi","year":"2020","unstructured":"Elakabawi K, Huang X, Shar SA, Al-Masry H, Smith J, Johnson L, et al. Predictors of suboptimal coronary blood flow after primary angioplasty and its implications on short-term outcomes in patients with acute anterior STEMI. BMC Cardiovasc Disord. 2020;20(1):391.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"5416_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.293.9.1063","volume":"293","author":"GW Stone","year":"2005","unstructured":"Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293(9):1063\u201372.","journal-title":"JAMA"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05416-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05416-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05416-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:29:02Z","timestamp":1768843742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05416-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5416"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05416-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The study protocol was reviewed by the Tsukazaki Hospital Ethics Committee, which determined that formal approval could be waived due to the retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all patients for participation and publication of anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}